The management of persistent or recurrent variceal bleeding after injection sclerotherapy by somatostatin

HPB Surg. 1992 Jun;5(4):221-6; discussion 226-7. doi: 10.1155/1992/86987.

Abstract

Sixteen patients with persistent (n = 11) or recurrent (n = 5) variceal bleeding after injection sclerotherapy and balloon tamponade were treated with an intravenous infusion of somatostatin 250 micrograms/h. Somatostatin infusion successfully controlled the bleeding in 15 of the 16 patients but one rebled after 72 h of treatment. In one patient with poor liver function (Child's C) bleeding was not controlled by somatostatin, further injection sclerotherapy or balloon tamponade of the oesophagus. The results of this study, although uncontrolled and with a small number of patients, suggest that somatostatin is a very effective treatment for the control of post-injection sclerotherapy variceal bleeding.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Balloon Occlusion
  • Catheterization
  • Esophageal and Gastric Varices / complications*
  • Gastrointestinal Hemorrhage / drug therapy
  • Gastrointestinal Hemorrhage / etiology
  • Gastrointestinal Hemorrhage / therapy*
  • Humans
  • Infusions, Intravenous
  • Middle Aged
  • Recurrence
  • Sclerotherapy*
  • Somatostatin / administration & dosage*

Substances

  • Somatostatin